Christopher Bunka
Chief Executive Officer at Lexaria Bioscience Corp.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Lexaria Bioscience Corp., 2 years.
Lexaria Bioscience Corp.
Director · Chief Executive Officer
Chief executive roles
Lexaria Bioscience Corp.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Lexaria Bioscience Corp. | Gift | −100,000 | — | — |
| Jul 30, 2025 | Lexaria Bioscience Corp. | Open-market purchase | +11,900 | $0.91 | $10,829 |
| Jul 29, 2025 | Lexaria Bioscience Corp. | Open-market purchase | +15,600 | $0.92 | $14,352 |
| Jan 7, 2025 | Lexaria Bioscience Corp. | Grant or award | +100,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.